A memo that purports to summarize a meeting held by members of a biotech trade group suggests deep concern about RFK Jr.’s ...

Novo Nordisk's top executives ignored internal warnings that the company was not sufficiently prepared for the launch of its ...

In 2007, Pharmalot officially launched; a year later, as newspapers reeled from the financial crisis, Silverman took a buyout. The story could have ended there. But over the years, Silverman (and ...

WIKIMEDIA, KEN HAWKINS Each day, Ed Silverman, a long-time blogger and reporter, would start his morning post on Pharmalot with the chipper greeting, “Pharmalot, Pharmalittle,” plus a few words on the ...

After a brief hiatus, the Pharmalot blog has found a new home with The Wall Street Journal as part of its ongoing commitment to provide must-read coverage of the pharmaceutical industry. The plan ...

And so, another working week is about to come to an end, although this was a relatively quiet few days, given that summer vacation time is drawing to a close. In fact, the moment will be ...

We also hope to hold yet another listening party with Mrs. Pharmalot, where the rotation will likely include this, this, this, this and this. And what about you?

Pharmalot reports that among its many shortcomings, Able did not report samples that failed to pass quality control tests, instead retesting until they got the results they needed.

The pharmaceutical industry is the "real culprit," he says in the Pharmalot blog post. "I'm all for them making a profit, but they have a social responsibility to make them affordable while making ...

Earlier this year, its DePuy Synthes medical device unit cut all travel--except that of sales reps--for the rest of this year, hoping to cut those costs by 25%, Pharmalot notes.